Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β

  • Authors:
    • Xiaowen Li
    • Weiwei Zhang
    • Lingli Liang
    • Xiaoqun Duan
    • Jianzhi Deng
    • Yuehan Zhou
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacology, College of Pharmacy, Guilin Medical University, Guilin, Guangxi 541004, P.R. China, Department of Medical Oncology, The Affiliated Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China, Guangxi Key Laboratory of Embedded Technology and Intelligent System, Guilin University of Technology, Guilin, Guangxi 541004, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2841-2850
    |
    Published online on: February 27, 2020
       https://doi.org/10.3892/etm.2020.8571
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Glioblastoma is the most common malignancy of the central nervous system, and patients typically have a poor prognosis. Previous studies indicate a gender bias in the development of glioblastoma; women are at a lower risk compared with men, suggesting that estrogen may confer protective effects. Icaritin, a prenylflavonoid derivative from a Chinese herb of the Epimedium genus, selectively regulates the estrogen receptor (ER) and possesses anti‑cancer properties. The aim of the present study was to investigate the protective effects of icaritin on glioblastoma and its underlying mechanisms, with a particular focus on its association with the ER. The results demonstrated that icaritin inhibited the growth of C6 and U87‑MG glioblastoma cells in a dose‑ and time‑dependent manner. At a concentration of 12.5 µM, icaritin induced apoptosis, which was characterized by the increased expression of the cleaved forms of caspases 3, 7, 8 and 9 and poly (ADP‑ribose) polymerase, downregulation of BCL2 apoptosis regulator and upregulation of BCL2‑associated X, apoptosis regulator expression. Additionally, icaritin inhibited the migration of C6 and U87‑MG cells. The protein expression levels of matrix metalloproteinase (MMP)‑2 and MMP‑9 were also downregulated following icaritin treatment. Furthermore, icaritin treatment increased the expression of estrogen receptor (ER)β and the phosphatase and tensin (PTEN) homolog oncoprotein, thus reducing the expression of downstream targets of PTEN; protein kinase B (Akt) and phosphorylated Akt. Subsequent experiments demonstrated that icaritin cooperates with 17β‑estradiol to inhibit the growth of glioblastoma cells, and the inhibition of ERβ with the ERβ‑specific antagonist ICI 182,780, attenuated the anti‑glioblastoma effects of icaritin. In conclusion, the results of the present study demonstrate that the anti‑glioblastoma effects of icaritin may be mediated by its modulation of ERβ.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Figure 10

View References

1 

Miller CR and Perry A: Glioblastoma. Arch Pathol Lab Med. 131:397–406. 2007.PubMed/NCBI View Article : Google Scholar

2 

Wirsching HG, Galanis E and Weller M: Glioblastoma. Handb Clin Neurol. 134:381–397. 2016.PubMed/NCBI View Article : Google Scholar

3 

Das S and Marsden PA: Angiogenesis in glioblastoma. N Engl J Med. 369:1561–1563. 2013.PubMed/NCBI View Article : Google Scholar

4 

Burns DM, D'Ambrogio A, Nottrott S and Richter JD: CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation. Nature. 473:105–108. 2011.PubMed/NCBI View Article : Google Scholar

5 

Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT and Koepsell TD: Epidemiology of intracranial meningioma. Cancer. 72:639–648. 1993.PubMed/NCBI View Article : Google Scholar

6 

Azcoitia I, Arevalo MA and Garcia-Segura LM: Neural-derived estradiol regulates brain plasticity. J Chem Neuroanat. 89:53–59. 2018.PubMed/NCBI View Article : Google Scholar

7 

Simpson ER: Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 86:225–230. 2003.PubMed/NCBI View Article : Google Scholar

8 

Ogawa S, Tsukahara S, Choleris E and Vasudevan N: Estrogenic regulation of social behavior and sexually dimorphic brain formation. Neurosci Biobehav Rev: Oct 27, 2018 (Epub ahead of print).

9 

Naftolin F, Ryan KJ and Petro Z: Aromatization of androstenedione by the anterior hypothalamus of adult male and female rats. Endocrinology. 90:295–298. 1972.PubMed/NCBI View Article : Google Scholar

10 

Batistatou A, Kyzas PA, Goussia A, Arkoumani E, Voulgaris S, Polyzoidis K, Agnantis NJ and Stefanou D: Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours. J Neurooncol. 77:17–23. 2006.PubMed/NCBI View Article : Google Scholar

11 

Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou AG and Agnantis NJ: Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol. 130:405–410. 2004.PubMed/NCBI View Article : Google Scholar

12 

Wu B, Chen Y, Huang J, Ning Y, Bian Q, Shan Y, Cai W, Zhang X and Shen Z: Icariin improves cognitive deficits and activates quiescent neural stem cells in aging rats. J Ethnopharmacol. 142:746–753. 2012.PubMed/NCBI View Article : Google Scholar

13 

Li Z, Meng X and Jin L: Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells. Am J Transl Res. 8:4628–4643. 2016.PubMed/NCBI

14 

Dell'Agli M, Galli GV, Dal Cero E, Belluti F, Matera R, Zironi E, Pagliuca G and Bosisio E: Potent inhibition of human phosphodiesterase-5 by icariin derivatives. J Nat Prod. 71:1513–1517. 2008.PubMed/NCBI View Article : Google Scholar

15 

Zhu S, Wang Z, Li Z, Peng H, Luo Y, Deng M, Li R, Dai C, Xu Y, Liu S and Zhang G: Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3. Oncotarget. 6:10460–10472. 2015.PubMed/NCBI View Article : Google Scholar

16 

Ma H, He X, Yang Y, Li M, Hao D and Jia Z: The genus Epimedium: An ethnopharmacological and phytochemical review. J Ethnopharmacol. 134:519–541. 2011.PubMed/NCBI View Article : Google Scholar

17 

Li W, Winters A, Poteet E, Ryou MG, Lin S, Hao S, Wu Z, Yuan F, Hatanpaa KJ, Simpkins JW and Yang SH: Involvement of estrogen receptor beta5 in the progression of glioma. Brain Res. 1503:97–107. 2013.PubMed/NCBI View Article : Google Scholar

18 

Akagi T, Murata K, Shishido T and Hanafusa H: v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Mol Cell Biol. 22:7015–7023. 2002.PubMed/NCBI View Article : Google Scholar

19 

Zhou C, Gu J, Zhang G, Dong D, Yang Q, Chen MB and Xu D: AMPK-autophagy inhibition sensitizes icaritin-induced anti-colorectal cancer cell activity. Oncotarget. 8:14736–14747. 2017.PubMed/NCBI View Article : Google Scholar

20 

Yang JG, Lu R, Ye XJ, Zhang J, Tan YQ and Zhou G: Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling. Int J Mol Sci. 18(E132)2017.PubMed/NCBI View Article : Google Scholar

21 

Ma T, Li ZJ, Wang LN, Li Z, Mu XL, Lyu Y and Xi YM: Effect of Icaritin on K562 cell proliferation and intracellular reactive oxygen species. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 24:1003–1007. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).

22 

Guo Y, Zhang X, Meng J and Wang ZY: An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. Eur J Pharmacol. 658:114–122. 2011.PubMed/NCBI View Article : Google Scholar

23 

Sareddy GR, Nair BC, Gonugunta VK, Zhang QG, Brenner A, Brann DW, Tekmal RR and Vadlamudi RK: Therapeutic significance of estrogen receptor beta agonists in gliomas. Mol Cancer Ther. 11:1174–1182. 2012.PubMed/NCBI View Article : Google Scholar

24 

Xu B, Jiang C, Han H, Liu H, Tang M, Liu L, Ji W, Lu X, Yang X, Zhang Y and Liu Y: Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling. Clin Exp Pharmacol Physiol. 42:1296–1307. 2015.PubMed/NCBI View Article : Google Scholar

25 

Kabat GC, Etgen AM and Rohan TE: Do steroid hormones play a role in the etiology of glioma? Cancer Epidemiol Biomarkers Prev. 19:2421–2427. 2010.PubMed/NCBI View Article : Google Scholar

26 

McKinley BP, Michalek AM, Fenstermaker RA and Plunkett RJ: The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg. 93:932–939. 2000.PubMed/NCBI View Article : Google Scholar

27 

Warner M, Huang B and Gustafsson JA: Estrogen receptor β as a pharmaceutical target. Trends Pharmacol Sci. 38:92–99. 2017.PubMed/NCBI View Article : Google Scholar

28 

Dey P, Barros RP, Warner M, Ström A and Gustafsson JA: Insight into the mechanisms of action of estrogen receptor beta in the breast, prostate, colon, and CNS. J Mol Endocrinol. 51:T61–T74. 2013.PubMed/NCBI View Article : Google Scholar

29 

Chen MF, Qi L, Li Y, Zu XB, Dai YQ and Zhang P: Icaritin induces growth inhibition and apoptosis of human prostatic smooth muscle cells in an estrogen receptor-independent manner. Amino Acids. 38:1505–1513. 2010.PubMed/NCBI View Article : Google Scholar

30 

Yang L, Wang Y, Chen P, Hu J, Xiong Y, Feng D, Liu H, Zhang H, Yang H and He J: Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression. Endocrinology. 152:4537–4549. 2011.PubMed/NCBI View Article : Google Scholar

31 

Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I, Giordano F, Casaburi I, Catalano S, De Amicis F, et al: Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle. 11:2911–2921. 2012.PubMed/NCBI View Article : Google Scholar

32 

Liu X, Wang L, Chen J, Ling Q, Wang H, Li S, Li L, Yang S, Xia M and Jing L: Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway. Mol Med Rep. 11:1516–1522. 2015.PubMed/NCBI View Article : Google Scholar

33 

Chen P, Zhao D, Li J, Liang X, Li J, Chang A, Henry VK, Lan Z, Spring DJ, Rao G, et al: Symbiotic macrophage-glioma cell interactions reveal synthetic lethality in PTEN-Null glioma. Cancer Cell. 35:868–884, e6. 2019.PubMed/NCBI View Article : Google Scholar

34 

Altiok N, Ersoz M and Koyuturk M: Estradiol induces JNK-dependent apoptosis in glioblastoma cells. Oncol Lett. 2:1281–1285. 2011.PubMed/NCBI View Article : Google Scholar

35 

Robertson JF: ICI 182,780 (Fulvestrant)-the first oestrogen receptor down-regulator - current clinical data. Br J Cancer 85. (Suppl 2):S11–S14. 2001.PubMed/NCBI View Article : Google Scholar

36 

Dauvois S, White R and Parker MG: The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci. 106:1377–1388. 1993.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li X, Zhang W, Liang L, Duan X, Deng J and Zhou : Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β. Exp Ther Med 19: 2841-2850, 2020.
APA
Li, X., Zhang, W., Liang, L., Duan, X., Deng, J., & Zhou, . (2020). Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β. Experimental and Therapeutic Medicine, 19, 2841-2850. https://doi.org/10.3892/etm.2020.8571
MLA
Li, X., Zhang, W., Liang, L., Duan, X., Deng, J., Zhou, ."Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β". Experimental and Therapeutic Medicine 19.4 (2020): 2841-2850.
Chicago
Li, X., Zhang, W., Liang, L., Duan, X., Deng, J., Zhou, ."Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β". Experimental and Therapeutic Medicine 19, no. 4 (2020): 2841-2850. https://doi.org/10.3892/etm.2020.8571
Copy and paste a formatted citation
x
Spandidos Publications style
Li X, Zhang W, Liang L, Duan X, Deng J and Zhou : Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β. Exp Ther Med 19: 2841-2850, 2020.
APA
Li, X., Zhang, W., Liang, L., Duan, X., Deng, J., & Zhou, . (2020). Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β. Experimental and Therapeutic Medicine, 19, 2841-2850. https://doi.org/10.3892/etm.2020.8571
MLA
Li, X., Zhang, W., Liang, L., Duan, X., Deng, J., Zhou, ."Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β". Experimental and Therapeutic Medicine 19.4 (2020): 2841-2850.
Chicago
Li, X., Zhang, W., Liang, L., Duan, X., Deng, J., Zhou, ."Natural product‑derived icaritin exerts anti‑glioblastoma effects by positively modulating estrogen receptor β". Experimental and Therapeutic Medicine 19, no. 4 (2020): 2841-2850. https://doi.org/10.3892/etm.2020.8571
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team